146953-14-2

Upstream product

• 146953-10-8 1,1-dimethylethyl -<2-<<3-(1H-indol-3-yl)-2-methyl-1-oxo-2-<<(phenylmethoxy)carbonyl>amino>propyl>amino>-1-phenylethyl>carbamate 
• 141971-07-5 methyl α-methyl-N-<(phenylmethoxy)carbonyl>-D-tryptophanate 
• 146953-09-5 α-methyl-N-<(phenylmethoxy)carbonyl>-D-tryptophan 
• 96551-27-8 α-methyl-(R)-tryptophan methyl ester 
• 66709-08-8 pimelic acid monomethyl ester 
• 146953-11-9 1,1-dimethylethyl -<2-<<2-amino-3-(1H-indol-3-yl)-2-methyl-1-oxopropyl>amino>-1-phenylethyl>carbamate 

Downstream Products

• 146953-18-6 -7-<<2-<<2-<<(1,1-dimethylethoxy)carbonyl>amino>-2-phenylethyl>amino>-1-(1H-indol-3-ylmethyl)-1-methyl-2-oxoethyl>amino>-7-oxoheptanoic acid 
• 146929-49-9 -7-<<2-<(2-amino-2-phenylethyl)amino>-1-(1H-indol-3-ylmethyl)-1-methyl-2-oxoethyl>amino>-7-oxoheptanoic acid monohydrochloride 

Relevant academic research and scientific papers

Synthesis of conformationally constrained macrocyclic analogs of the potent and selective CCK-B antagonist CI-988

A series of conformationally constrained analogs of the potent CCK-B antagonist CI-988 were prepared and evaluated for their CCK-B binding affinity. A macrolactamization reaction leading to the conformation of 11 to 14-membered rings was also investigated